on 13 Aug 2024
Last Applicant/ Owned by
Rietlistrasse 4
Staad
CH
9422
Serial Number
97648630 filed on 26th Oct 2022
Registration Number
7476146 registered on 13th Aug 2024
Filing Basis
1. intent to use
2. filed as use application
3. use application currently
Disclaimer
NO DATA
Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and mo Read More
Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics
08th Sep 2022
08th Sep 2022
Packaging and filling articles to the order and specification of others; Warehouse services
08th Sep 2022
08th Sep 2022
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
01st Sep 2022
01st Sep 2022
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
01st Sep 2022
01st Sep 2022
Custom manufacture of medicines and diagnostics for others; Custom manufacturing for others in the pharmaceutical, diagnostic, veterinary, biotechnology and chemistry fields
08th Sep 2022
08th Sep 2022
No 97648630
No Service Mark
No 09799037-126
No
No
No
No
No
No
No
No
26.17.12 -
Chevrons and angles
Status Date | Action Taken |
---|---|
13th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
13th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
07th Jul 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
07th Jul 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
25th May 2024 | STATEMENT OF USE PROCESSING COMPLETE |
25th May 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
26th Apr 2024 | TEAS STATEMENT OF USE RECEIVED |
26th Apr 2024 | USE AMENDMENT FILED |
14th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
19th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |